Dr. Silver was formerly the Chief Executive of CHS Healthcare, the leading independent provider of hospital discharge services and Continuing Healthcare in the UK. She oversaw the successful sale of CHS to a trade buyer in 2021. Prior to joining CHS Healthcare, she ran Specialty Operations for McKesson UK. She has headed the global healthcare practice at Brunswick, advising clients across the life sciences sector with a focus on corporate positioning, crisis management and campaigns. She previously led the GE Global Strategic Marketing Organization with a focus on Neuroscience and Primary Care offerings. She also spent nine years in global roles within the pharmaceutical sector, including Eisai and Bristol Myers Squibb, where she was responsible for the development, launch and commercialization of innovative therapies in the fields of neuroscience, psychiatry and pain management. Having qualified as a doctor in London and practiced as an anaesthetist, she is fully familiar with the UK public sector and now serves as a non-executive for an NHS Trust. Dr. Silver received her BS from the University of Bristol and her medical degree from the University of London.